Conservative treatment for Peyronie's disease: an update

被引:7
作者
El-Sakka, Ahmed I.
Yassin, Aksam A. [1 ]
机构
[1] Segeberger Klin, Hamburg, Germany
关键词
conservative treatment; intralesional injection; oral treatment; Peyronie's disease;
D O I
10.1517/14656566.9.1.53
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Many theories have been proposed to explain the cause of Peyronie's disease (PD); however, the true pathogenesis of PD remains an enigma. As a result, the treatment of PD remains a dilemma and new therapies continue to evolve. The last two decades have witnessed a phenomenal advance in the understanding of the pathophysiology and natural history of PD. The efficacy of conservative treatment for PD is not settled. In this update review the authors provide information of the status of conservative therapy for PD. Conservative treatment is always the initial treatment in most of the cases. This kind of therapy consists of different modalities of treatment such as oral, intralesional or topical therapy. Other treatments including iontophoresis, extracorporeal shock wave, radiotherapy, ultrasound and laser have also been reported.
引用
收藏
页码:53 / 63
页数:11
相关论文
共 94 条
[1]   Stimulation of collagen production in an in vitro model for Peyronie's disease [J].
Ahuja, SK ;
Sikka, SC ;
Hellstrom, WJG .
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 1999, 11 (04) :207-212
[2]  
Apaydin E, 1998, INT J IMPOT RES, V10, pS57
[3]  
Astorga R, 2000, Arch Esp Urol, V53, P665
[4]   Intralesional verapamil prevents the progression of Peyronie's disease [J].
Bennett, Nelson E. ;
Guhring, Patricia ;
Mulhall, John P. .
UROLOGY, 2007, 69 (06) :1181-1184
[5]   Acetyl-L-carnitine vs tamoxifen in the oral therapy of Peyronie's disease: a preliminary report [J].
Biagiotti, G ;
Cavallini, G .
BJU INTERNATIONAL, 2001, 88 (01) :63-67
[6]  
Bivalacqua TJ, 2001, J ANDROL, V22, P497
[7]   A rat model of Peyronie's disease associated with a decrease in erectile activity and an increase in inducible nitric oxide synthase protein expression [J].
Bivalacqua, TJ ;
Diner, EK ;
Novak, TE ;
Vohra, Y ;
Sikka, SC ;
Champion, HC ;
Kadowitz, PJ ;
Hellstrom, WJG .
JOURNAL OF UROLOGY, 2000, 163 (06) :1992-1998
[8]  
BODNER H, 1953, Trans West Sect Am Urol Assoc, V20, P32
[9]   Treatment of Peyronie's disease with local interferon-α 2b [J].
Brake, M ;
Loertzer, H ;
Horsch, R ;
Keller, H .
BJU INTERNATIONAL, 2001, 87 (07) :654-657
[10]   Treatment of Peyronie's disease with oral pentoxifylline [J].
Brant, WO ;
Dean, RC ;
Lue, TF .
NATURE CLINICAL PRACTICE UROLOGY, 2006, 3 (02) :111-115